- Home
- CRVS vs KLTR Comparison
CRVS vs KLTR Comparison
Compare CRVS & KLTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- KLTR
- Stock Information
- Founded
- CRVS 2014
- KLTR 2006
- Country
- CRVS United States
- KLTR United States
- Employees
- CRVS N/A
- KLTR N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- KLTR EDP Services
- Sector
- CRVS Health Care
- KLTR Technology
- Exchange
- CRVS Nasdaq
- KLTR Nasdaq
- Market Cap
- CRVS 305.4M
- KLTR 302.6M
- IPO Year
- CRVS 2016
- KLTR 2021
- Fundamental
- Price
- CRVS $5.75
- KLTR $1.63
- Analyst Decision
- CRVS Strong Buy
- KLTR Buy
- Analyst Count
- CRVS 4
- KLTR 3
- Target Price
- CRVS $15.00
- KLTR $2.83
- AVG Volume (30 Days)
- CRVS 518.7K
- KLTR 277.5K
- Earning Date
- CRVS 08-07-2025
- KLTR 08-07-2025
- Dividend Yield
- CRVS N/A
- KLTR N/A
- EPS Growth
- CRVS N/A
- KLTR N/A
- EPS
- CRVS N/A
- KLTR N/A
- Revenue
- CRVS N/A
- KLTR $181,350,000.00
- Revenue This Year
- CRVS N/A
- KLTR $3.43
- Revenue Next Year
- CRVS N/A
- KLTR $2.96
- P/E Ratio
- CRVS N/A
- KLTR N/A
- Revenue Growth
- CRVS N/A
- KLTR 2.56
- 52 Week Low
- CRVS $2.54
- KLTR $1.06
- 52 Week High
- CRVS $10.00
- KLTR $2.82
- Technical
- Relative Strength Index (RSI)
- CRVS 65.10
- KLTR 48.46
- Support Level
- CRVS $5.28
- KLTR $1.38
- Resistance Level
- CRVS $5.64
- KLTR $1.66
- Average True Range (ATR)
- CRVS 0.30
- KLTR 0.09
- MACD
- CRVS 0.03
- KLTR 0.02
- Stochastic Oscillator
- CRVS 77.70
- KLTR 85.71
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About KLTR Kaltura Inc.
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.